ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
78 hedge funds and large institutions have $50.2M invested in Aralez Pharmaceuticals Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
-5
Holders Change %
-6.02%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
27
Reduced
23
Closed
12
Calls
$677K
Puts
$403K
Net Calls
+$274K
Net Calls Change
+$528K
Top Buyers
| 1 |
BlackRock
New York
|
+$1.95M |
| 2 |
BC
Broadfin Capital
New York
|
+$856K |
| 3 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$626K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$418K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$310K |
Top Sellers
| 1 |
TLCM
Tiger Legatus Capital Management
New York
|
-$8.75M |
| 2 |
AC
Armistice Capital
New York
|
-$4.57M |
| 3 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$2.67M |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$2.54M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$665K |
